Cargando…

Epigenetic acquisition of inducibility of type III cytotoxicity in P. aeruginosa

BACKGROUND: Pseudomonas aeruginosa, an opportunistic pathogen, is often encountered in chronic lung diseases such as cystic fibrosis or chronic obstructive pneumonia, as well as acute settings like mechanical ventilation acquired pneumonia or neutropenic patients. It is a major cause of mortality an...

Descripción completa

Detalles Bibliográficos
Autores principales: Filopon, Didier, Mérieau, Annabelle, Bernot, Gilles, Comet, Jean-Paul, LeBerre, Rozenne, Guery, Benoit, Polack, Benoit, Guespin-Michel, Janine
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1488876/
https://www.ncbi.nlm.nih.gov/pubmed/16734902
http://dx.doi.org/10.1186/1471-2105-7-272
_version_ 1782128354466463744
author Filopon, Didier
Mérieau, Annabelle
Bernot, Gilles
Comet, Jean-Paul
LeBerre, Rozenne
Guery, Benoit
Polack, Benoit
Guespin-Michel, Janine
author_facet Filopon, Didier
Mérieau, Annabelle
Bernot, Gilles
Comet, Jean-Paul
LeBerre, Rozenne
Guery, Benoit
Polack, Benoit
Guespin-Michel, Janine
author_sort Filopon, Didier
collection PubMed
description BACKGROUND: Pseudomonas aeruginosa, an opportunistic pathogen, is often encountered in chronic lung diseases such as cystic fibrosis or chronic obstructive pneumonia, as well as acute settings like mechanical ventilation acquired pneumonia or neutropenic patients. It is a major cause of mortality and morbidity in these diseases. In lungs, P. aeruginosa settles in a biofilm mode of growth with the secretion of exopolysaccharides in which it is encapsulated, enhancing its antibiotic resistance and contributing to the respiratory deficiency of patients. However, bacteria must first multiply to a high density and display a cytotoxic phenotype to avoid the host's defences. A virulence determinant implicated in this step of infection is the type III secretion system (TTSS), allowing toxin injection directly into host cells. At the beginning of the infection, most strains isolated from patients' lungs possess an inducible TTSS allowing toxins injection or secretion upon in vivo or in vitro activation signals. As the infection persists most of the bacteria permanently loose this capacity, although no mutations have been evidenced. We name "non inducible" this phenotype. As suggested by the presence of a positive feedback circuit in the regulatory network controlling TTSS expression, it may be due to an epigenetic switch allowing heritable phenotypic modifications without genotype's mutations. RESULTS: Using the generalised logical method, we designed a minimal model of the TTSS regulatory network that could support the epigenetic hypothesis, and studied its dynamics which helped to define a discriminating experimental scenario sufficient to validate the epigenetic hypothesis. A mathematical framework based on formal methods from computer science allowed a rigorous validation and certification of parameters of this model leading to epigenetic behaviour. Then, we demonstrated that a non inducible strain of P. aeruginosa can stably acquire the capacity to be induced by calcium depletion for the TTSS after a short pulse of a regulatory protein. Finally, the increased cytotoxicity of a strain after this epigenetic switch was demonstrated in vivo in an acute pulmonary infection model. CONCLUSION: These results may offer new perspectives for therapeutic strategies to prevent lethal infections by P. aeruginosa by reverting the epigenetic inducibility of type III cytotoxicity.
format Text
id pubmed-1488876
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-14888762006-07-06 Epigenetic acquisition of inducibility of type III cytotoxicity in P. aeruginosa Filopon, Didier Mérieau, Annabelle Bernot, Gilles Comet, Jean-Paul LeBerre, Rozenne Guery, Benoit Polack, Benoit Guespin-Michel, Janine BMC Bioinformatics Research Article BACKGROUND: Pseudomonas aeruginosa, an opportunistic pathogen, is often encountered in chronic lung diseases such as cystic fibrosis or chronic obstructive pneumonia, as well as acute settings like mechanical ventilation acquired pneumonia or neutropenic patients. It is a major cause of mortality and morbidity in these diseases. In lungs, P. aeruginosa settles in a biofilm mode of growth with the secretion of exopolysaccharides in which it is encapsulated, enhancing its antibiotic resistance and contributing to the respiratory deficiency of patients. However, bacteria must first multiply to a high density and display a cytotoxic phenotype to avoid the host's defences. A virulence determinant implicated in this step of infection is the type III secretion system (TTSS), allowing toxin injection directly into host cells. At the beginning of the infection, most strains isolated from patients' lungs possess an inducible TTSS allowing toxins injection or secretion upon in vivo or in vitro activation signals. As the infection persists most of the bacteria permanently loose this capacity, although no mutations have been evidenced. We name "non inducible" this phenotype. As suggested by the presence of a positive feedback circuit in the regulatory network controlling TTSS expression, it may be due to an epigenetic switch allowing heritable phenotypic modifications without genotype's mutations. RESULTS: Using the generalised logical method, we designed a minimal model of the TTSS regulatory network that could support the epigenetic hypothesis, and studied its dynamics which helped to define a discriminating experimental scenario sufficient to validate the epigenetic hypothesis. A mathematical framework based on formal methods from computer science allowed a rigorous validation and certification of parameters of this model leading to epigenetic behaviour. Then, we demonstrated that a non inducible strain of P. aeruginosa can stably acquire the capacity to be induced by calcium depletion for the TTSS after a short pulse of a regulatory protein. Finally, the increased cytotoxicity of a strain after this epigenetic switch was demonstrated in vivo in an acute pulmonary infection model. CONCLUSION: These results may offer new perspectives for therapeutic strategies to prevent lethal infections by P. aeruginosa by reverting the epigenetic inducibility of type III cytotoxicity. BioMed Central 2006-05-30 /pmc/articles/PMC1488876/ /pubmed/16734902 http://dx.doi.org/10.1186/1471-2105-7-272 Text en Copyright © 2006 Filopon et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Filopon, Didier
Mérieau, Annabelle
Bernot, Gilles
Comet, Jean-Paul
LeBerre, Rozenne
Guery, Benoit
Polack, Benoit
Guespin-Michel, Janine
Epigenetic acquisition of inducibility of type III cytotoxicity in P. aeruginosa
title Epigenetic acquisition of inducibility of type III cytotoxicity in P. aeruginosa
title_full Epigenetic acquisition of inducibility of type III cytotoxicity in P. aeruginosa
title_fullStr Epigenetic acquisition of inducibility of type III cytotoxicity in P. aeruginosa
title_full_unstemmed Epigenetic acquisition of inducibility of type III cytotoxicity in P. aeruginosa
title_short Epigenetic acquisition of inducibility of type III cytotoxicity in P. aeruginosa
title_sort epigenetic acquisition of inducibility of type iii cytotoxicity in p. aeruginosa
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1488876/
https://www.ncbi.nlm.nih.gov/pubmed/16734902
http://dx.doi.org/10.1186/1471-2105-7-272
work_keys_str_mv AT filopondidier epigeneticacquisitionofinducibilityoftypeiiicytotoxicityinpaeruginosa
AT merieauannabelle epigeneticacquisitionofinducibilityoftypeiiicytotoxicityinpaeruginosa
AT bernotgilles epigeneticacquisitionofinducibilityoftypeiiicytotoxicityinpaeruginosa
AT cometjeanpaul epigeneticacquisitionofinducibilityoftypeiiicytotoxicityinpaeruginosa
AT leberrerozenne epigeneticacquisitionofinducibilityoftypeiiicytotoxicityinpaeruginosa
AT guerybenoit epigeneticacquisitionofinducibilityoftypeiiicytotoxicityinpaeruginosa
AT polackbenoit epigeneticacquisitionofinducibilityoftypeiiicytotoxicityinpaeruginosa
AT guespinmicheljanine epigeneticacquisitionofinducibilityoftypeiiicytotoxicityinpaeruginosa